Every single analyst who covers this AI hardware company revised estimates upward in the past seven days; the company has beaten EPS estimates in each of the last four quarters, revenue is expected to grow 52% year over year on Monday, and earnings growth is pegged at 66%.
Get the full breakdown of whether the custom networking hardware story, the hyperscaler relationships, and Monday’s Q2 report add up to a position worth taking before the market closes.
AI reset (Sponsored)
Some AI stocks have captured most of the headlines—but one veteran analyst believes the next opportunities may lie elsewhere.
In his latest free briefing, he shares a simple "Sell This, Buy That" strategy, along with a Hotlist and Hitlist of stocks he's watching as the AI landscape continues to evolve.
Get the Free Hotlist
Monday’s Print Is the Moment the Market Has Been Waiting to Confirm
Celestica Inc. (NYSE: CLS) reports Q2 after the close on Monday, July 27, with the conference call on July 28. The stock closed at $334.75 on Wednesday and trades around $338 in pre-market on Friday.
The consensus Q2 revenue estimate is $4.39 billion against $2.89 billion a year ago. Consensus EPS is $2.31 against $1.39 a year ago.
Those are not incremental improvement numbers. Those are the numbers of a business in the middle of a structural transformation that has already been running for several quarters.
Every analyst who covers this stock raised estimates in the past seven days. Fifteen up, zero down in both the seven-day and thirty-day windows.
That is not a coincidence heading into an earnings print. It means the people who study this business most closely have been getting better information from management, industry contacts, and hyperscaler capex announcements and are all moving in the same direction simultaneously.
Q2 revenue consensus $4.39B vs $2.89B a year ago: 52% growth from the same quarter last year.
Q2 EPS consensus $2.31 vs $1.39 a year ago: 66% earnings growth expected.
All 15 covering analysts raised estimates in the last seven days: Zero down revisions.
Four consecutive quarters of positive earnings surprises: Averaging roughly 8% above estimate each quarter.
Q1 FY26 EPS actual $2.16 vs estimate $2.08: The most recent beat confirms the streak is live.
Management’s own Q2 guidance is $4.15B to $4.45B in revenue and $2.14 to $2.34 in adjusted EPS. Consensus sits at the high end of that range. Full-year 2026 revenue expectations have been raised to $19 billion.
Action: Buy before the close. Exit if Q2 EPS comes in below $2.10, which breaks the beat streak and signals CCS momentum has slowed.
The Wealth Strategy (Sponsored)
His official salary? $400,000 a year.
Yet his returns point to something far bigger: Up to $250,000 per month… from just one place.
It’s not property.
It’s not equities.
So what’s really generating this kind of income — and why is it gaining traction now
Find out how to get started for under $20.
The CCS Segment Is Running the Show and Growing Fast Enough to Reframe the Whole Business
The Connectivity and Cloud Solutions segment, known as CCS, is where the AI hardware work lives. It represented 80% of total revenue last quarter at $3.24 billion. The Q2 estimate for CCS alone is $3.58 billion, up from $2.07 billion in the year-ago quarter.
That is not the profile of a legacy electronics manufacturing business. That is the profile of a company that has repositioned itself entirely around the infrastructure buildout driving the biggest capital expenditure cycle in technology history.
CCS co-develops custom 800G and 1.6T switches and compute racks directly with hyperscaler engineering teams. Once you are designed into a hyperscaler’s infrastructure stack, you are in for years. Design cycles are long, and switching costs are real.
CCS segment 80% of total revenue at $3.24B last quarter: The business has fundamentally reoriented.
Enterprise revenue within CCS: 101% year-over-year growth last quarter: Hyperscaler AI compute demand doubled.
Communications revenue within CCS: 69% year-over-year growth: 800G switch deployment driving the number.
CCS segment margin at 8.6%: Structurally better than traditional EMS work.
Q2 CCS estimate $3.58B vs $2.07B a year ago: The segment is nearly doubling year over year.
The AMD Helios platform engagement is a concrete example. That is co-development work, not contract manufacturing.
Action: On the call, watch CCS margin vs the 8.6% baseline. Expansion confirms the mix shift is sustainable. Flat or declining margins raise pricing questions.
AI shift (Sponsored)
Artificial intelligence is changing the way companies operate—and one new initiative linked to Elon Musk is attracting attention.
According to a veteran market analyst, the biggest opportunity may not be the household names, but a little-known company supporting the technology behind the scenes.
His free briefing reveals the trend and the stocks he's watching.
Watch the Free Briefing
Hyperscaler Capex Is Not Slowing. It Is Accelerating Into This Print.
The five largest hyperscalers, Meta, Amazon, Microsoft, Google, and Oracle, have each raised their 2026 capital expenditure outlooks meaningfully in recent months.
That capital has to flow somewhere. For the AI networking and compute infrastructure layer, it flows to a very short list of hardware suppliers capable of co-designing and building at this scale and speed. Celestica is on that list.
The 800G to 1.6T transition is already underway, and Celestica has confirmed engagement with multiple customers on next-generation platforms. Being early to a new switching generation captures the majority of early volume.
Hyperscaler capex raised across all five major customers: The demand environment heading into Monday is stronger than three months ago.
800G to 1.6T networking transition actively ramping: Early design cycle position is the competitive moat.
Full-year 2027 consensus revenue $27.1B vs $19.22B this year: The market is already modeling continued acceleration.
The 2027 consensus of $27.1 billion in revenue against this year’s $19.22 billion implies the analyst community expects growth to continue accelerating, not plateauing.
That is an unusual expectation to hold for a company of any size and reflects genuine confidence in the hyperscaler demand pipeline.
Action: Watch for 1.6T design win timing commentary. A named customer or production timeline confirms the next cycle is on schedule.
The Four-Quarter Beat Streak and What It Says About Management Credibility
Four consecutive quarters of positive earnings surprises tell you something specific: management is guiding conservatively relative to what the business is actually delivering. The surprises over the last four quarters were 12.65%, 6.03%, 7.27%, and 3.84%.
That pattern shows beats narrowing slightly as the business scales and the Street gets more accurate, but still consistently positive.
Monday’s Q3 guidance is the number the market will focus on as much as Q2 itself. A management team with a four-quarter beat streak and consistently conservative guidance has earned the right to be believed when they set expectations.
Four consecutive positive EPS surprises averaging roughly 8% above estimate: A consistent pattern, not random luck.
Q1 FY26 beat of 3.84% was the narrowest in four quarters: Street is getting more accurate, still undershooting.
Q3 consensus $5.01B revenue and $2.69 EPS: Guidance above those levels triggers another upward revision cycle.
All revisions running upward before the print, not after, means conviction is building ahead of the number.
Action: Q3 guidance above $4.8B means hold or add. Below $4.5B means something in the near-term pipeline shifted.
What the AI Draft Got Wrong About Valuation and the Real Comparison
The AI draft compared Celestica to Jabil and Flex and called those comps stale. That part was right. But the draft then said the stock is “off 52-week highs” without noting that the 52-week high is $655.50 and the current price is $334.75.
That is not a modest pullback. The stock is roughly 50% below its 52-week high. That context changes the framing entirely.
The stock is 50% off its high because of multiple compression across the AI hardware sector in early 2026, not because the business deteriorated. Forward P/E at 29 to 31 times is still not cheap in absolute terms, but it is much more defensible than earlier this year.
52-week range $220.49 to $655.50: The stock is 50% below its 52-week high, not modestly off it.
Forward P/E approximately 29 to 31x on $10.30 full-year EPS: Elevated but more defensible after the correction.
Stock up roughly 116% year over year despite the high-to-now correction: Business trajectory intact, multiple pulled back.
Jabil forward P/E roughly 19x vs Celestica 29 to 31x: The premium reflects CCS growth, not legacy EMS.
You are paying a growth multiple for a business growing at 50% to 66% year over year with zero downward revisions this week. That math works differently than paying the same multiple for a business that is slowing.
Action: If the stock gaps up Tuesday morning, wait for a pullback toward $300 to $310 for a better entry. Do not chase the open.
Poll: How many stocks do you typically hold at any given time?
The Risks Are Real, and Customer Concentration Is the One That Matters Most
Customer concentration is the most immediate risk. A meaningful share of revenue comes from a small number of hyperscaler customers. If any one of them delays programs or brings design work in-house, the revenue impact shows up fast.
At 29 to 31 times forward earnings, there is no room for an operational miss. A below-consensus quarter compresses earnings and the multiple simultaneously.
ASIC in-sourcing is the longer-duration risk. If hyperscalers reduce dependence on merchant networking hardware over three to five years, the CCS addressable market narrows. Not a Monday problem, but real.
Customer concentration in a small number of hyperscalers: One program shift hits the revenue line immediately.
29 to 31x forward multiple leaves no margin for error: A miss compresses both earnings and the multiple.
ASIC in-sourcing risk over a multi-year horizon: Long-duration structural risk, not a near-term concern.
Action: Hard stop at $290. Q2 miss plus Q3 guidance below $4.5B means both execution and momentum have broken.
Final Word: Every Analyst Agreed This Week. Monday Tells You Whether They Were Right.
Fifteen analysts raised estimates. Zero went down. Four consecutive beats. Revenue growing 52%, earnings growing 66%. CCS at 80% of revenue and accelerating. The 1.6T cycle still ahead of it.
The stock is 50% below the 52-week high because the multiple was repriced, not because the business broke. Monday tells you whether the repricing was an overreaction.
Buy before the close at $334 to $340. Hard stop $290. Target $410 to $450.
Setup Scorecard
Entry Window: $334 to $340 before Monday’s close. Newsletter goes out Saturday. Earnings Monday after close.
Catalyst Watch: Q2 earnings Monday, July 27 after close, Q3 guidance vs $5.01B consensus, CCS margin commentary vs 8.6% baseline, 1.6T design win timing, and Tuesday morning price reaction.
Upside Setup: Q2 beats $2.31 consensus, Q3 guided above $4.8B, CCS margin holds or expands. Estimate revision cycle continues into Q3. Target $410 to $450 over six to twelve months as FY2027 consensus of $27.1B revenue materializes.
Downside Cushion: Four consecutive beat streak creating execution credibility, all 15 analyst revisions positive this week, full-year 2026 guidance already raised to $19B, 52-week low $220.49 as the technical floor.
What Moves It Next: Q2 revenue vs $4.39B consensus, Q2 EPS vs $2.31 consensus, Q3 guidance, CCS segment margin update, and any 1.6T design win commentary on the call.
That's our coverage for today; thanks for reading! Reply to this email with feedback or any value names you want me to check out.
Best Regards,
—Noah Zelvis
Undervalued Edge
